Prospective external validation of an accelerated ... - Semantic Scholar
Recommend Documents
of Population Health, The University of Manchester, Vaughan House, ..... 60. de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H. Creatinine.
Jun 28, 2018 - James P Sheppard senior research fellow1, Una Martin professor2, ... Cambridge, UK; 5Memorial University of Newfoundland, St John's, ...
4 days ago - James P Sheppard senior research fellow1, Una Martin professor2, Paramjit Gill professor3, Richard. Stevens associate professor1, FD ...
Jun 13, 2017 - blood culture sets and a urine for culture (all patients) as well as nasal swab for .... Urine was taken for culture ..... Kocuria kristinae. Ð. 2.
Nov 14, 2010 - European Prospective Investigation into. Cancer and Nutrition. FRS. Framingham risk score. HLÏ2. HosmerâLemeshow Ï2 statistic. Electronic ...
Jul 7, 2015 - The earthquake triggered powerful tsunami waves that killed nearly ... major nuclear disaster at the Fukushima Daiichi nuclear power plant was.
been previously reported [7] and, can lead to toxicity, including hepatic veno-occlusive disease [8,9] as well as graft rejection or suboptimal antitumor activity [10] ...
What do you think âexternal validationâ? Most researchers misunderstand âexternal validationâ is validation for unknown data. It is outside of science. So, we ...
The National Comprehensive Cancer Network. (NCCN) recommends active surveillance or observation as an alternative treatment option for managing prostate.
Received 23 December 2008; received in revised form 24 May 2009; accepted 28 May 2009. Abstract ... The observed mortality was 5.2% (eight deaths).
Jun 6, 2014 - 2Unidade de Cuidados Intensivos Neurocríticos, Hospital de São José, Centro ... Salciccioli JD, Cristia C, Chase M, Giberson T, Graver A, Gautam S, .... M, Bertolini G: External validation of the Simplified Acute Physiology.
22 Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K. Risk assessment tools ... 34 Kanis JA, Hans D, Cooper C, et al. Task Force of the FRAX ...
Nov 8, 2011 - David Hajage1, Yann de Rycke1, Marc Bollet2, Alexia Savignoni1, ...... Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA (2010) ...
with polyps (including reference standard) available on the National Cancer. Institutes National Biomedical Imaging Archive (NBIA)4. These cases include.
mortality according to clinical prediction rules [5]. This same meta-analysis identified the Pulmonary Embolism. Severity Index (PESI), simplified PESI (sPESI) ...
2Centre of Bioinformatics, 2nd Faculty of Medicine, Charles University Praha, Czech Republic ... of a 10-core biopsy nomogram by Chun et al. (2007). Material ...
Apr 4, 2008 - Manoj Kumar Singh,1 Uma Shanker Tiwary,2 and Yong-Hoon Kim1. 1 Sensor .... We also use the Shannon entropy, and, it is given as follows:.
Key words: Glibenclamide, Blend Uniformity, Assay of Glibenclamide, Process validation of. Glibenclamide, Glibenclamide tablets. 1. INTRODUCTION.
Redhat 6.2/7.1 and Fedora) to browsers [14] (i.e., IE, Firefox, Mozilla), and web servers [15] (i.e., ISS, Apache). The results reported in the literature show that.
Jul 22, 2015 - to generate the accelerated durability testing PSD profiles, which can be ... design and statistical analysis of the accelerated vibration test.
Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain.pdf. Val
Apr 21, 2011 - chromatographyâtandem mass spectrometry method for Pacific ciguatoxin-1 in fish flesh and comparison with the mouse neuroblastoma assay.
[1] R. Brightwell, W. Lawry, A. B. Maccabe, and R. Riesen, âPortals. 3.0: Protocol ... David. A. Wheeler, available from http://www.dwheeler.com/sloccount. [3] K. T. ...
Prospective external validation of an accelerated ... - Semantic Scholar
Chen WK, Chang WH, Flaws DF, George PM, Richards AM: A 2-h diagnostic protocol ... Florkowski CM, Kline JA, Peacock WF, Maisel AS, Lim SH, Lamanna A,.
Kelly and Klim International Journal of Emergency Medicine 2014, 7:42 http://www.intjem.com/content/7/1/42
ORIGINAL RESEARCH
Open Access
Prospective external validation of an accelerated (2-h) acute coronary syndrome rule-out process using a contemporary troponin assay Anne-Maree Kelly1,2* and Sharon Klim1
Abstract Background: Recently there have been efforts to derive safe, efficient processes to rule out acute coronary syndrome (ACS) in emergency department (ED) chest pain patients. We aimed to prospectively validate an ACS assessment pathway (the 2-Hour Accelerated Diagnostic Protocol to Assess Patients with Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker (ADAPT) pathway) under pragmatic ED working conditions. Methods: This prospective cohort study included patients with atraumatic chest pain in whom ACS was suspected but who did not have clear evidence of ischaemia on ECG. Thrombolysis in myocardial infarction (TIMI) score and troponin (TnI Ultra) were measured at ED presentation, 2 h later and according to current national recommendations. The primary outcome of interest was the occurrence of major adverse cardiac events (MACE) including prevalent myocardial infarction (MI) at 30 days in the group who had a TIMI score of 0 and had presentation and 2-h TnI assays
